Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05561270 · ClinicalTrials.gov registry record · NA
Light Exposure on Pain in Hypermobile Ehlers-Danlos Syndrome
A NA study of Pain, Chronic and Ehlers-Danlos Syndrome, sponsored by New York Institute of Technology.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05561270: Recruiting NA study of Pain, Chronic and Ehlers-Danlos Syndrome, sponsored by New York Institute of Technology.
NCT05561270 is a NA study of Pain, Chronic and Ehlers-Danlos Syndrome that is actively recruiting participants, run by New York Institute of Technology. The registered enrollment target is 30 participants, below the 721-participant average among 48 other Pain, Chronic trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05561270, a NA study of Pain, Chronic and Ehlers-Danlos Syndrome, is actively recruiting participants, sponsored by New York Institute of Technology.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Chronic pain is a major complaint among many individuals living with hypermobile Ehlers Danlos Syndrome (hEDS) and may have a severe impact on quality of life and activities of daily living. Given the complexity of the disease's pathophysiology, effective treatments are limited. This investigation will examine the impacts of green light exposure on subject-reported pain severity and symptoms. Knowing whether this intervention can improve pain and quality of life in this population may offer valuable guidance to clinicians who treat hEDS patients and to hEDS patients themselves.
Conditions Studied
Interventions
- DEVICE White LED light
- DEVICE Green LED light
Study Locations (1)
New York
- New York Institute of Technology College of Osteopathic Medicine - Old Westbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-11-21 |
| Est. Completion | 2025-11 |
| Phase | NA |
What NCT05561270 shows while recruiting
NCT05561270 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 721-participant average among 48 other Pain, Chronic trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Pain, Chronic appearing as the primary indexed condition, and to 2 interventions - of which White LED light is the first listed.
NCT05561270 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05561270 about?
NCT05561270 is a clinical study titled "Light Exposure on Pain in Hypermobile Ehlers-Danlos Syndrome". Chronic pain is a major complaint among many individuals living with hypermobile Ehlers Danlos Syndrome (hEDS) and may have a severe impact on quality of life and activities of daily living. Given the complexity of the disease's pathophysiology, effective treatments are limited. This investigation w...
What is the current status of trial NCT05561270?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-11-21. Estimated completion is 2025-11.
What conditions does trial NCT05561270 study?
This clinical trial studies the following conditions: Pain, Chronic, Ehlers-Danlos Syndrome.
What interventions are being tested in trial NCT05561270?
The interventions under investigation include: White LED light (DEVICE), Green LED light (DEVICE).
Who is sponsoring clinical trial NCT05561270?
This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05561270 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05561270's enrollment target sits among peer trials
30 40th of 48 higher than 6 of 48 other Pain, Chronic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Chronic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
RECRUITING · NA
-
Pain and Weight Treatment: Development and Trial of PAW
RECRUITING · NA
-
VR and Cooled Genicular Nerve Radio Frequency Ablation for Chronic Knee Pain
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Pain and Opioid Management in Older Adults
RECRUITING · NA
-
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI